首页> 美国卫生研究院文献>other >Acetylcholine Inhibits Monomeric C-Reactive Protein Induced Inflammation Endothelial Cell Adhesion and Platelet Aggregation; A Potential Therapeutic?
【2h】

Acetylcholine Inhibits Monomeric C-Reactive Protein Induced Inflammation Endothelial Cell Adhesion and Platelet Aggregation; A Potential Therapeutic?

机译:乙酰胆碱抑制单体C反应蛋白诱导的炎症内皮细胞粘附和血小板聚集。潜在的治疗方法?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objectives: In this study, we examined the possibility of using targeted antibodies and the potential of small molecular therapeutics (acetylcholine, nicotine and tacrine) to block the pro-inflammatory and adhesion-related properties of monomeric C-reactive protein (mCRP).>Methods: We used three established models (platelet aggregation assay, endothelial leucocyte binding assay and monocyte inflammation via ELISA and Western blotting) to assess the potential of these therapeutics.>Results: The results of this study showed that monocyte induced inflammation (raised tumor necrosis factor-alpha-TNF-α) induced by mCRP was significantly blocked in the presence of acetylcholine and nicotine, whilst tacrine and targeted antibodies (clones 8C10 and 3H12) had less of or no significant effects. Western blotting confirmed the ability of acetylcholine to inhibit mCRP-induced cell signaling phosphorylation of extracellular signal regulated kinase 1/2 (ERK1/2), p38 and nuclear factor-kappa B (NF-κB). There was no evidence of direct binding between small molecules and mCRP. mCRP also induced endothelial cell-monocyte adhesion in a dose dependent fashion, however, both acetylcholine and nicotine as well as targeting antibodies notably inhibited adhesion. Finally, we investigated their effects on mCRP-induced platelet aggregation. All three small molecules significantly attenuated platelet aggregation as did the antibody 8C10, although 3H12 had a weaker effect.>Discussion: Acetylcholine and to a lesser extent nicotine show potential for therapeutic inhibition of mCRP-induced inflammation and cell and platelet adhesion. These results highlight the potential of targeted antibodies and small molecule therapeutics to inhibit the binding of mCRP by prevention of membrane interaction and subsequent activation of cellular cascade systems, which produce the pro-inflammatory effects associated with mCRP.
机译:>目标:在这项研究中,我们研究了使用靶向抗体的可能性以及小分子疗法(乙酰胆碱,尼古丁和他克林)阻断单体C-的促炎性和黏附相关特性的潜力。反应蛋白(mCRP)。>方法:我们使用了三种建立的模型(血小板聚集测定,内皮白细胞结合测定和ELISA和Western blotting单核细胞炎症)来评估这些疗法的潜力。>结果::这项研究的结果显示,在乙酰胆碱和尼古丁存在的情况下,mCRP诱导的单核细胞诱导的炎症(肿瘤坏死因子-TNF-α升高)被显着阻断,而他克林和靶向抗体(克隆8C10和3H12)的影响很小或没有。 Western印迹证实乙酰胆碱具有抑制mCRP诱导的细胞外信号调节激酶1/2(ERK1 / 2),p38和核因子-κB(NF-κB)的细胞信号磷酸化的能力。没有证据表明小分子和mCRP之间直接结合。 mCRP还以剂量依赖性方式诱导内皮细胞-单核细胞粘附,但是,乙酰胆碱和尼古丁以及靶向抗体均显着抑制粘附。最后,我们研究了它们对mCRP诱导的血小板聚集的影响。尽管3H12的作用较弱,所有三个小分子均显着减弱了血小板凝集,与8C10抗体一样。>讨论:乙酰胆碱和较小程度的尼古丁具有治疗性抑制mCRP诱导的炎症和细胞凋亡的潜力。血小板粘附。这些结果突显了靶向抗体和小分子疗法通过预防膜相互作用和随后激活细胞级联系统而抑制mCRP结合的潜力,这会产生与mCRP相关的促炎作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号